Estimation of Immunoglobulin A, Immunoglobulin G, and Immunoglobulin M Antibody Levels in Laboratory Mice Balb/c Infected with Entamoeba histolytica and Treatment with Aqueous Extracts of Cyperus rotundus and Thymus serpyllum

Authors

DOI:

https://doi.org/10.25156/ptj.v10n1y2020.pp126-129

Keywords:

Antibody levels, Entamoeba histolytica, Thymus serpyllum, Cyperus rotundus, Dysentery

Abstract

Sixty Balb/c mice (Mus musculus) were used in the present study. It was conducted out in the animal house of the Department of Biology/College of Education for Women. The mice were infected with Entamoeba histolytica isolated from positive stool samples obtained from children in pediatric hospital in Kirkuk city governorate followed by treatment with aqueous extract of Cyperus rotundus and Thymus serpyllum. Results revealed a significant increase of P < 0.05 in immunoglobulin A, immunoglobulin G,, and immunoglobulin M antibody levels among infected mice when it was compared with the control and treated groups of aqueous extracts of studied plant. This indicates the efficacy of these extracts as treatment.

Downloads

Download data is not yet available.

References

Abd-Alla, M. D., T. Jackson, T. Rogers, S. Reddy and J. I. Ravdin. 2006. Mucosal immunity to asymptomatic Entamoeba histolytica and Entamoeba dispar infection is associated with a peak intestinal anti-lectin immunoglobulin a antibody response. Infect. Immun. 74: 3897-3903.

Al Quraishi, M. A. and S. H. Al-Sultany. 2017. Immunoglobulin profile of E. histolytica and E. dispar in human sera. J. Bio. Innov. 6: 203-213.

Al-Areeqi, M. A., H. Sady, H. M. Al-Mekhlafi, T. S. Anuar, A. H. Al-Adhroey, W. M. Atroosh and Y. L. Lau. 2017. First molecular epidemiology of Entamoeba histolytica, E. dispar and E. moshkovskii infections in Yemen: Different species-specific associated risk factors. Trop. Med. Int. Health. 22: 493-504.

Ali, I. K. M. 2015. Intestinal amebae. Clin. Lab. Med. 35: 393-422.

AL-Kahfaji, M. S. A. 2010. Some Immunological Criteria for Patient Infected with Entamoeba histolytica and Histological Changes in White Mice. In: Thesis for Degree of Master in Biology College of Science for Women, University of Babylon, Babylon.

AL-Mukhtar, A. M. and W. J. Barwari. 2008. Effectiveness of albendazole against viability of Entamoeba histolytica in mice and rabbits. Ann. Coll. Med. Mosul. 34: 64-68.

Al-Snafi, A. E. 2016. A review on Cyperus rotundus a potential medicinal plant. IOSR J. Pharm. 6: 32-48.

Anwar, S. A. 2014. Epidemiological and Immunological Study of Infection with E. histolytica and E. dispar Among Children Attending Kirkuk Pediatric Hospital with Trial Treatment by Using Deferoxamine and Zinc as Alternative Treatment for Amoebiasis. In: Thesis for Doctoral Degree (Ph.D.), College of Pure Science, University of Tikrit, Tikrit.

Cheesbrough, M. 2005. District Laboratory Practice in Tropical Countries. 2nd ed. Cambridge University Press, Cambridge, United Kingdom. p200-202.

Ghasemi, E., M. Rahdar and M. Rostami. 2015. Prevalence of Entamoeba histolytica/dispar in drinking water in the city of Shush, Khuzestan Province in 2011. Int. J. Curr. Microbiol. App. Sci. 4: 582-588.

Gwairgi, M. A. and R. Ghildyal. 2018. Nuclear transport in Entamoeba histolytica: Knowledge gap and therapeutic potential. Parasitology. 145: 1378-1387.

Houpt, E. R., D. J. Glembocki, T. G. Obrig, C. A. Moskaluk, L. A. Lockhart, R. L. Wright and W. A. Petri. 2002. The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells. J. Immunol. 169: 4496-4503.

Inam, A., S. Mittal, M. S. Rajala, F. Avecilla and A. Azam. 2016. Synthesis and biological evaluation of 4-(2-(dimethylamino) ethoxy) benzohydrazide derivatives as inhibitors of Entamoeba histolyica. Eur. J. Med. Chem. 124: 445-455.

Jarillo-Luna, R. A., R. Campos-Rodrıguez and V. Tsutsumi. 2002. Entamoeba histolytica: Immunohistochemical study of hepatic amoebiasis in mouse. Neutrophils and nitric oxide as possible factors of resistance. Exp. Parasitol. 101: 40-56.

Jirků-pomajbÍková, K., I. Čepička, B. Kalousová, M. Jirků, F. Stewart, B. Levecke and K. J. Petrželková. 2016. Molecular identification of Entamoeba species in savanna woodland chimpanzees (Pan troglodytes schweinfurthii). J. Parasitol. 143: 741-748.

Kamala, A., S. K. Middha and C. S. Karigar. 2018. Plants in traditional medicine with special reference to Cyperus rotundus L.: A review. 3 Biotech. 8: 309.

Lemee, V., I. Zaharia, G. Nevez, M. Rabodonirina, J. J. Ballet and L. Favennec. 2000. Metronidazole and albendazole susceptibilityof 11 clinical isolates of Giardia duodenalis from France. J. Ant. Chem. 46: 819-821.

Levecke, B., P. Dorny, F. Vercammen, L. G. Visser, M. Van Esbroeck, J. Vercruysse, J., and Verweij, J. J. 2015. Transmission of Entamoeba nuttalli and Trichuris trichiura from nonhuman primates to humans. Emerg. Infect. Dis. 21: 1871.

Lydia, J. and D. Sudarsanam. 2014. Docking of a Cyperus rotundus compound ‘15-Hydroxy-4-oxo-10-pentadecynoic acid lactone’ with anti-diabetic drug targets: A comparative study. Int. J. Fund. Appl. Sci. 3: 17-21.

Macpherson, A., K. McCoy, F. Johansen and P. Brandtzaeg. 2008. The immune geography of IgA induction and function. Mucosal Immunol. 1: 11-22.

Mortimer, L. and K. Chadee. 2010. The immunopathogenesis of Entamoeba histolytica. Exp. Parasitol. 126: 366-380.

Nabavi, S. M., A. Marchese, M. Izadi, V. Curti, M. Daglia and S. F. Nabavi. 2015. Plants belonging to the genus thymus as antibacterial agents: From farm to pharmacy. Food Chem. 173: 339-347.

Nozaki, T. and A. Bhattacharya. 2015. Amebiasis: Biology and pathogenesis of Entamoeba. Springer, Berlin, Germany.

Peerzada, A. M., H. H. Ali, M. Naeem, M. Latif, A. H. Bukhari and A. Tanveer. 2015. Cyperus rotundus L.: Traditional uses, phytochemistry, and pharmacological activities. J. Ethnopharmacol. 174: 540-560.

Peterson, K. M., U. Singh and W. A. Jr. Petri. 2011. Enteric amebiasis. In: Tropical Infectious Diseases: Principles, Pathogens and Practice. WB Saunders, Philadelphia, Pennsylvania, PA. p614-622.

Pineda, E. and D. Perdomo. 2017. Entamoeba histolytica under oxidative stress: What countermeasure mechanisms are in place? Cells. 6: 44.

Sastry, A. S. and S. Bhat. 2018. Essentials of Medical Parasitology. 2nd ed. Jaypee Brothers, Medical Publishers Pvt. Limited, New Delhi.

Singh, N., B. R. Pandey, P. Verma, M. Bhalla and M. Gilca. 2012. Phyto-pharmacotherapeutics of Cyperus rotundus Linn. (Motha): An overview. Indian J. Nat. Prod, Resour. 3: 467-476.

Sivapalan, S. R. and P. Jeyadevan. 2012. Physico-chemical and phytochemical study of rhizome of Cyperus rotundus Linn. Int. J. Pham. Technol. 1: 42-46.

Yimer, M., Y. Zenebe, W. Mulu, B. Abera and J. M. Saugar. 2017. Molecular prevalence of Entamoeba histolytica/dispar infection among patients attending four health centres in North-West Ethiopia. Trop. Doct. 47: 11-15.

Published

2020-06-30

How to Cite

Hussein, F. K., Mahmoud, A. J., & Yousif, B. J. (2020). Estimation of Immunoglobulin A, Immunoglobulin G, and Immunoglobulin M Antibody Levels in Laboratory Mice Balb/c Infected with Entamoeba histolytica and Treatment with Aqueous Extracts of Cyperus rotundus and Thymus serpyllum. Polytechnic Journal, 10(1), 126-129. https://doi.org/10.25156/ptj.v10n1y2020.pp126-129

Issue

Section

Research Articles